₹86.97
▲ +0.25 +0.29%
17 Jul 2026
NSE Listed
Bal Pharma Ltd. (BALPHARMA)
Volume: 31,026Avg Vol 1W: 1,33,506.2Avg Vol 1M: 53,820.6552W Range:₹60₹103.9
Key Ratios
Checked 16h agoMarket Cap₹138 Cr
Current Price₹86.97
Previous Close₹86.72
High / Low (52w)₹103.9 / ₹60
Volume31,026
Avg Vol (1W)1,33,506.2
Avg Vol (1M)53,820.65
Stock P/E38.37
Book Value₹51.65
Dividend Yield139%
ROE7.64%
ROA168.3%
Revenue (TTM)₹305 Cr
Revenue Growth-10.6%
Profit Margin201.5%
Total Debt₹31 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹3.95
P/B1.67
Debt / Equity1.94
50 DMA₹84.12
200 DMA₹77.23
Day change+0.29%
Price Chart
₹86.97▼ 13.32% · 1Y
2025-07-172026-07-16
20-day avg volume: 54K shares
Pros
- Pays a dividend yield of 139.0%.
- Company is almost debt-free.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹74 Cr | ₹74 Cr | ₹73 Cr | ₹82 Cr | ₹66 Cr | ₹74 Cr | ₹88 Cr | ₹84 Cr |
| EBITDA | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹7 Cr | ₹4 Cr | ₹5 Cr | ₹7 Cr | ₹7 Cr |
| Net Profit | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹5 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹4 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹213 Cr | ₹226 Cr | ₹173 Cr | ₹252 Cr | ₹286 Cr | ₹305 Cr | ₹342 Cr | ₹305 Cr |
| EBITDA | ₹12 Cr | ₹12 Cr | ₹-1 Cr | ₹16 Cr | ₹20 Cr | ₹17 Cr | ₹24 Cr | ₹22 Cr |
| Net Profit | ₹3 Cr | ₹4 Cr | ₹-12 Cr | ₹5 Cr | ₹6 Cr | ₹3 Cr | ₹7 Cr | ₹7 Cr |
| EPS | 1.96 | 2.67 | -8.62 | 3.34 | 3.79 | 1.68 | 4.96 | 4.54 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹260 Cr | ₹261 Cr | ₹238 Cr | ₹240 Cr | ₹261 Cr | ₹313 Cr | ₹320 Cr | ₹336 Cr |
| Total Liabilities | ₹200 Cr | ₹201 Cr | ₹193 Cr | ₹187 Cr | ₹202 Cr | ₹249 Cr | ₹248 Cr | ₹258 Cr |
| Equity | ₹60 Cr | ₹60 Cr | ₹45 Cr | ₹53 Cr | ₹58 Cr | ₹64 Cr | ₹72 Cr | ₹77 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹2 Cr | ₹10 Cr | ₹23 Cr | ₹22 Cr | ₹28 Cr | ₹-1 Cr | ₹27 Cr | ₹22 Cr |
| Investing | ₹-4 Cr | ₹-8 Cr | ₹-5 Cr | ₹-6 Cr | ₹-9 Cr | ₹-22 Cr | ₹-19 Cr | ₹-15 Cr |
| Financing | ₹4 Cr | ₹0 Cr | ₹-20 Cr | ₹-17 Cr | ₹-17 Cr | ₹24 Cr | ₹-1 Cr | ₹-8 Cr |
| Free Cash Flow | ₹2 Cr | ₹10 Cr | ₹23 Cr | ₹22 Cr | ₹28 Cr | ₹-1 Cr | ₹27 Cr | ₹22 Cr |
Shareholding
Promoter 50.86% Institutions 0.15% Public 48.99%
Efficiency & Working Capital
ROCE9.2%
Interest Coverage1.3
Dividend Payout—
Debtor Days111 d
Inventory Days124 d
Payable Days98 d
Cash Conversion Cycle137 d
Working Capital Days235 d
Shareholding Details
As of 2026-06-30
Promoter50.9%
FII0.1%
DII0%
Institutions0.1%
Public49%
Promoter Pledge0%
No. of Shareholders14,974
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 51.6% | 51.2% | 51.2% | 51.2% | 50.9% | 50.9% | 50.9% | 50.9% | 50.9% | 50.9% | 50.9% | 50.9% |
| FIIs | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 48.3% | 48.6% | 48.6% | 48.6% | 49% | 49% | 49% | 49% | 48.9% | 49% | 49% | 49% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 15,529 | 15,060 | 14,772 | 15,014 | 16,007 | 15,667 | 15,723 | 15,826 | 15,774 | 15,520 | 15,214 | 14,974 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Shailesh Siroya | Shareholding of Promoter and Promoter Group | 17.2% | 27,45,459 |
| Micro Labs Limited | Shareholding of Promoter and Promoter Group | 12.6% | 20,11,736 |
| Anita Siroya | Shareholding of Promoter and Promoter Group | 6.6% | 10,49,220 |
| Prakash Chandra Jain | Public Shareholding | 3.4% | 5,48,311 |
| Ram Keshav Murthy | Public Shareholding | 3.3% | 5,27,600 |
| Anand Surana | Shareholding of Promoter and Promoter Group | 3.3% | 5,25,686 |
| Chandraprakash Dheerajmal Siroya | Shareholding of Promoter and Promoter Group | 3.1% | 4,86,420 |
| Dilip Surana | Shareholding of Promoter and Promoter Group | 3% | 4,74,994 |
| Naresh D P | Public Shareholding | 1.9% | 3,00,000 |
| Shreya Mardia | Public Shareholding | 1.9% | 3,00,000 |
| Asha Tapidas Dodhia | Public Shareholding | 1.8% | 2,93,247 |
| Archana Surana | Shareholding of Promoter and Promoter Group | 1.8% | 2,84,996 |
| Gautam Chand Mehta | Public Shareholding | 1.2% | 1,84,966 |
| Monica Surana | Shareholding of Promoter and Promoter Group | 1.1% | 1,79,909 |
| Dilip Surana (huf) | Shareholding of Promoter and Promoter Group | 1.1% | 1,69,995 |
| Anita Chandraprakash Siroya | Shareholding of Promoter and Promoter Group | 0.8% | 1,22,687 |
| Jivi Dheerajmal Siroya | Shareholding of Promoter and Promoter Group | 0.3% | 46,080 |
| Shrenik Siroya | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Shailesh Siroya | 0 | 0% | 2026-06-30 |
| Anita Siroya | 0 | 0% | 2026-06-30 |
| Anand Surana | 0 | 0% | 2026-06-30 |
| Dilip Surana | 0 | 0% | 2026-06-30 |
| Archana Surana | 0 | 0% | 2026-06-30 |
| Monica Surana | 0 | 0% | 2026-06-30 |
| Dilip Surana (huf) | 0 | 0% | 2026-06-30 |
| Shrenik Siroya | 0 | 0% | 2026-06-30 |
| Micro Labs Limited | 0 | 0% | 2026-06-30 |
| Chandraprakash Dheerajmal Siroya | 0 | 0% | 2026-06-30 |
| Anita Chandraprakash Siroya | 0 | 0% | 2026-06-30 |
| Jivi Dheerajmal Siroya | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Shailesh Siroya | ED / MD / Promoter | 2025 |
| Himesh Virupakshaya | E D & Wholetime Director | 2025 |
| H S Venkatesh | Independent Non Exe. Director | 2025 |
| Nicola Neeladri | Independent Non Exe. Director | 2025 |
| Jatish Sheth | Independent Non Exe. Director | 2025 |
| Ravindrakumar Kothari | Independent Non Exe. Director | 2025 |
| Abdul Basith | Company Sec. & Compli. Officer | 2025 |
| Bheekamchand Mukesh | Additional Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| manufacturing and marketing of phar | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹105 Cr | 46.5% |
| Other than India | ₹121 Cr | 53.5% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 25 | 16 | 16 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2025-09-18 | ₹1.2 (12%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 1 | 0 | 0 | 3 | 4 | 8 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 3 | 1 | 4 |
Insider / Designated-Person Trades
5 recent disclosure(s)
SHAILESH SIROYAAcquisition · 7,50,000
MICRO LABS LIMITED RevisedAcquisition · 3,00,900
MICRO LABS LIMITED RevisedAcquisition · 3,00,900
MICRO LABS LIMITEDAcquisition · 4,00,000
MICRO LABS LIMITEDAcquisition · 3,00,900
Substantial Acquisitions (SAST)
3 disclosure(s)
Pref. Allotment13/04/2022 · 7,50,000
Market23/11/2021 · 4,00,000
Market27/08/2021 · 3,00,900
Company Information
🌐 www.balpharma.com ↗
📍 21 & 22 Bommasandra Indl Area, Hosur Road, Bangalore, Karnataka, 560092
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search